How an AI agent can convert a variant research question into an evidence brief with databases, literature context, and review caveats
This workflow gives an AI agent a defined job, a bounded set of records, and a result a person can review. The agent reads the relevant Life Science Research context, applies the rules in the prompt, and keeps the source behind every recommendation. It returns a proposed handoff rather than taking consequential actions on its own.
Can an AI agent convert a variant research question into an evidence brief with databases, literature context, and review caveats?
Yes. Start with the scope, date range, decision rules, and fields that identify the right records. The agent can collect the evidence, compare states or sources, mark conflicts and missing data, and organize the result around the outcome above. A reviewer then checks the matches and judgment calls before approving messages, record updates, bookings, purchases, publishing, or other write actions. The guide below shows the records, boundaries, prompt, and handoff needed for this specific workflow.
What this agent helps you do
A Life Science Research variant evidence agent organizes information around a genetic variant, gene, phenotype, or disease context. It does not make clinical conclusions; it prepares evidence for expert review.
When to use this workflow
Use it for research triage, variant background, pathway exploration, study planning, or preparing a structured question for a scientist or clinician.
How Life Science Research gives the agent context
Connect the plugin and specify the variant, gene, disease area, organism, population context, and evidence types. Ask the agent to preserve caveats and avoid clinical advice.
Example starter prompt
Prepare a variant evidence brief for this research question. Separate database evidence, literature, population context, functional evidence, caveats, and recommended expert follow-up.Suggested workflow steps
The agent routes to relevant sources, gathers evidence by type, identifies conflicts or gaps, and prepares a cautious synthesis with next searches.
Normalize the variant notation and reference sequence before comparing sources. Keep population frequency, computational evidence, functional results, segregation, and database assertions in separate rows with their dates and review status.
Expected handoff
The handoff should include an evidence table, caveats, source context, and follow-up recommendations. It should be ready for expert review, not final diagnosis.
Questions this workflow answers
Could an agent gather the published evidence around a genetic variant while keeping population, assay, and clinical claims clearly separated?
Yes. Provide the normalized variant identifier, gene and transcript context, condition or phenotype, population, and the evidence sources the review may use. The agent can collect publication and database context, then organize it by evidence type. It should preserve genome build, transcript, nomenclature, and source date because an identifier mismatch can invalidate the comparison.
The evidence table can separate population frequency, computational predictions, functional assays, segregation, case observations, case-control data, and curated classifications. These categories are not interchangeable. A laboratory effect does not by itself establish clinical significance, and a database classification needs its criteria, review status, and date. Conflicting classifications should remain visible with their supporting sources.
Ask the agent to record study population, sample size, phenotype definition, assay system, direction of effect, limitations, and exact claim. It must not infer a diagnosis, penetrance, or treatment recommendation from incomplete evidence. Family data and other sensitive information should only appear within the authorized research scope.
The final handoff provides normalized identity, source-linked evidence, conflicts, caveats, missing data, and questions for a genetics or clinical expert. A qualified reviewer applies the appropriate classification framework and patient context. The agent reduces search and extraction work while preserving the boundary between published evidence and a professional clinical interpretation.
Variant normalization should retain genome build, transcript, reference and alternate alleles, coordinate, and protein consequence where available. Similar notation can describe a different transcript or locus, so unresolved mappings are excluded from the combined evidence table. The agent also checks source date and review status because a curated classification may have changed after an older publication. No single computational prediction, frequency record, or case observation is allowed to stand in for the expert framework.